0LOV - Verastem, Inc. (LSE) - Share Price and News

Verastem, Inc.
GB ˙ LSE ˙ US92337C2035
Basic Stats

The Factor Analysis chart (below right) shows a view of Verastem, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.

For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.

Market Cap
EV
Shares Out. 61.52 MM
Earnings Date
EPS (TTM) -2.71
Dividend Yield
Ex-Dividend Date
Borrow Rate
Short Shares Avail.
Short Interest
Short Float
Days to Cover
Risk Free Rate 4.17 %
Price Change (1 yr)
Volatility (1 yr)
Beta
Sharpe Ratio (1 yr)
Sortino Ratio (1 yr)
PE Ratio
Price/Book
Price/TBV
Book/Market
EBIT/EV
EBIT(3yr avg)/EV
ROA -1.58
ROE -4.16
ROIC -1.38
CROIC 0.67
OCROIC -0.99
Implied Volatility
Put/Call OI Ratio
Growth 49.49 /100
Profitability 34.63 /100
Quality Score 18.20 /100
Value Score
Momentum Score
Stability (Low Vol) Score
Analyst Sentiment
Fund Sentiment 35.65 /100
Insider Sentiment
Officer Sentiment
Dividend Score
QVM Score
Piotroski F-SCORE 2.00 /9
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target

The average one-year price target for Verastem, Inc. is US$14.43. The forecasts range from a low of US$12.28 to a high of US$19.64. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.

Update Frequency: Monthly

Record Date Projection Date High Low Median Average
2025-08-22 2026-08-22 19.64 12.28 13.35 14.43
Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for Verastem, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:
  • Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
  • Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
  • Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Date Analyst Prior Latest
Recommendation
Action
2024-07-08 Truist Securities Buy Buy Maintains
2024-05-29 Alliance Global Partners Buy Buy Maintains
2024-05-28 RBC Capital Outperform Outperform Maintains
2024-05-28 HC Wainwright & Co. Buy Buy Reiterate
2024-05-13 HC Wainwright & Co. Buy Buy Reiterate
2024-03-19 HC Wainwright & Co. Buy Buy Reiterate
2024-03-15 RBC Capital Outperform Outperform Reiterate
2023-11-15 Truist Securities Buy Buy Maintains
2023-09-29 B. Riley Securities Buy Buy Reiterate
2023-09-27 B. Riley Securities Buy Initiate
2023-08-29 Mizuho Buy Buy Reiterate
2023-08-09 RBC Capital Outperform Outperform Maintains
2023-07-11 Truist Securities Buy Buy Maintains
2023-07-06 Cantor Fitzgerald Overweight Overweight Reiterate
2023-07-03 RBC Capital Outperform Outperform Maintains
2023-06-27 Truist Securities Buy Buy Reiterate
2023-06-23 Truist Securities Buy Buy Reiterate
2023-06-15 Mizuho Neutral Buy Upgrade
2023-05-10 HC Wainwright & Co. Buy Maintains
2023-03-30 Mizuho Neutral Initiate
2023-03-15 RBC Capital Outperform Reiterate
2023-03-15 HC Wainwright & Co. Buy Reiterate
2022-11-07 HC Wainwright & Co. Buy Maintains
2022-10-05 BTIG Buy Maintains
2022-04-14 RBC Capital Outperform Initiate
2022-03-09 Truist Securities Buy Initiate
2021-07-20 HC Wainwright & Co. Buy Maintains
2021-07-01 Alliance Global Partners Buy Initiate
2021-05-24 BTIG Neutral Buy Upgrade
2021-05-13 HC Wainwright & Co. Buy Maintains
2020-05-11 H.C. Wainwright Buy Reiterate
2020-03-16 H.C. Wainwright Buy Maintains
2020-03-03 Cantor Fitzgerald Overweight Maintains
2019-05-10 Raymond James Outperform Market Perform Downgrade
2019-04-03 Cantor Fitzgerald Overweight Initiate
2019-03-14 Raymond James Outperform Outperform Maintains
2018-07-13 BTIG Research Buy Initiate
2018-05-02 Seaport Global Buy Initiate
2017-09-06 Cantor Fitzgerald Neutral Overweight Upgrade
2017-04-13 Oppenheimer Outperform Initiate
2017-03-24 H.C. Wainwright Buy Reiterate
2016-08-09 Jefferies Hold Maintains
2015-09-29 Jefferies Buy Hold Downgrade
2015-09-29 Cantor Fitzgerald Hold Maintains
2015-09-29 UBS Buy Neutral Downgrade
2015-09-28 JMP Securities Market Outperform Market Perform Downgrade
2015-09-28 Jefferies Buy Hold Downgrade
2015-09-28 Roth Capital Buy Neutral Downgrade
2015-09-28 Cantor Fitzgerald Buy Hold Downgrade
2015-09-28 Mizuho Buy Neutral Downgrade
2015-05-12 UBS Buy Maintains
2015-04-08 H.C. Wainwright Buy Initiate
2015-03-11 Jefferies Buy Maintains
2014-07-08 Oppenheimer Market Perform Initiate
2014-05-06 Deutsche Bank Buy Initiate
2013-07-29 Jefferies Buy Initiate
2013-07-08 Cantor Fitzgerald Buy Initiate
2013-03-13 Roth Capital Buy Initiate
2013-02-22 Guggenheim Buy Initiate
2013-02-08 JMP Securities Market Outperform Initiate
2024-08-13 Truist Securities Buy Buy Maintains
2024-07-24 B. Riley Securities Buy Buy Maintains
2024-08-09 RBC Capital Outperform Outperform Maintains
2025-04-10 Jefferies Buy Initiate
2024-09-30 Guggenheim Buy Initiate
2025-01-07 RBC Capital Outperform Outperform Maintains
2024-10-18 RBC Capital Outperform Outperform Reiterate
2024-10-18 Cantor Fitzgerald Overweight Reiterate
2024-10-18 HC Wainwright & Co. Buy Buy Reiterate
2024-12-19 Mizuho Outperform Outperform Maintains
2024-12-19 HC Wainwright & Co. Buy Buy Reiterate
2025-03-21 RBC Capital Outperform Outperform Maintains
2025-03-24 Guggenheim Buy Buy Maintains
2025-03-24 HC Wainwright & Co. Buy Buy Maintains
2025-01-24 Guggenheim Buy Buy Reiterate
2024-08-12 HC Wainwright & Co. Buy Buy Maintains
2025-01-31 B. Riley Securities Buy Buy Maintains
2025-05-09 HC Wainwright & Co. Buy Buy Maintains
2025-04-09 Mizuho Outperform Outperform Maintains
2025-08-08 RBC Capital Outperform Outperform Maintains
2025-06-25 RBC Capital Outperform Outperform Maintains
Other Listings
US:VSTM US$10.77
DE:2VSA
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista